NCT06237881 2026-02-18A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid TumorsM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting15 enrolled